PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 5235
 
  
 
C07K PEPTIDES 3133
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 2253
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 2152
 
  
 
B60N VEHICLE PASSENGER ACCOMMODATION NOT OTHERWISE PROVIDED FOR 260
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
C30B SINGLE-CRYSTAL GROWTH 254
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1106

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0070,836 CVHR SHAPE MEASUREMENT DEVICESJan 05, 16Mar 15, 18[A61B]
2018/0044,434 NOVEL ANTI-PAD4 ANTIBODYMar 07, 16Feb 15, 18[C07K]
2017/0361,297 EUTECTIC COLLOIDAL CRYSTAL, EUTECTIC COLLOIDAL CRYSTAL SOLIDIFIED BODY, AND METHODS FOR PRODUCING THEMDec 02, 15Dec 21, 17[B01J, C08L]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9815384 Wakefulness-maintenance apparatusJul 08, 13Nov 14, 17[B60K, A61B, B60N, A61M]
9700687 Medicine inhaler and medicine supply methodJun 23, 11Jul 11, 17[A61M]
9693726 Alertness device, seat, and method for determining alertnessOct 20, 14Jul 04, 17[A61B]
9234184 Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 1B, hepatitis C virus genome-replicating cells transfected with the same, and method for producing infectious hepatitis C virus particlesMar 30, 12Jan 12, 16[A61K, C12Q, C12N, C07K]
9206125 Use of compound binding to mSin3B that specifically binds to neuron restrictive silencer factor (NRSF)Feb 09, 11Dec 08, 15[A61K, C07D, C07C]
9133496 Material for screening for compound acting on ion channel and use thereofJun 29, 11Sep 15, 15[C12Q, C12N, G01N, C07K]
9017477 Process for producing colloidal crystal and colloidal crystalApr 30, 09Apr 28, 15[C01B, C30B]
8979761 Sleepiness assessment apparatusMay 26, 10Mar 17, 15[A61B]
8623608 Method for measuring glycoprotein, method for examining liver disease, reagent for quantitative determination of glycoprotein, and glycan-marker glycoprotein as an index for clinical conditions of liver diseaseJan 13, 12Jan 07, 14[G01N]
7963985 Instrument for ultraviolet irradiation and ultraviolet irradiating apparatusSep 20, 05Jun 21, 11[A61N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0302,009 Medicinal Agent for Prevention or Treatment of Diseases Associated with Intraocular Neovascularization and/or Intraocular Vascular HyperpermeabilityAbandonedFeb 01, 12Oct 09, 14[A61K]
2014/0057,286 Method for Measuring Glycoprotein, Method for Examining Liver Desease, Reagent for Quantitative Determination of Glycoprotein and Glycan-Marker Glycoprotein as an Index for Clinical Conditions of Liver DiseaseAbandonedOct 11, 13Feb 27, 14[G01N]
2013/0108,590 METHOD FOR PRODUCING CELL SHEETAbandonedMay 10, 11May 02, 13[C12N]
2013/0059,888 MEDICAMENT FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF ALZHEIMER-TYPE DEMENTIAAbandonedNov 07, 12Mar 07, 13[A61K, A61P]
2012/0301,478 Pharmaceutical for Preventing or Treating Disorders Accompanied by Ocular Angiogenesis and/or Elevated Ocular Vascular PermeabilityAbandonedJan 13, 11Nov 29, 12[A61K, A61P]
8318781 G-protein-conjugated receptor agonistExpiredApr 25, 08Nov 27, 12[A61K, A01N, C07D, C07C]
2011/0275,668 Compound with antimalarial activity and antimalarial drug containing the same as active ingredientAbandonedMay 16, 11Nov 10, 11[A61K, C07D, A61P]
7973027 Compound with antimalarial activity and antimalarial drug containing the same as active ingredientExpiredFeb 26, 07Jul 05, 11[A61K, C07D]
2011/0160,252 PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OR PREVENTION OF HBV INFECTIONAbandonedJun 18, 09Jun 30, 11[A61K, C07D, C07C, A61P]
2010/0035,927 MEDICAMENT FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF ALZHEIMER-TYPE DEMENTIAAbandonedJan 22, 08Feb 11, 10[A61K, A61P]
2008/0281,385 System and Method For Phototherapy With Semiconductor Light-Emitting ElementAbandonedDec 05, 06Nov 13, 08[A61B]
2006/0286,091 RelA-ASSOCIATED INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOFAbandonedApr 25, 06Dec 21, 06[A61K, G01N, C07K]
7119169 RelA-associated inhibitor, process for producing the same and utilization thereofExpiredFeb 27, 03Oct 10, 06[A61K]
6582933 Rel1A binding inhibitor, process for producing the same and utilization thereofExpiredJun 04, 01Jun 24, 03[C07H, C12N, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.